Comera Life Sciences to Participate in Four Upcoming Conferences

3 years ago

WOBURN, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life…

Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument

3 years ago

MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year

3 years ago

Asserts Certara’s leadership in advancing the development and approval of new drugs for patientsPRINCETON, N.J., April 27, 2023 (GLOBE NEWSWIRE)…

Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Investment Conference May 2, 2023

3 years ago

NORCROSS, Ga., April 27, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target…

PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023

3 years ago

PetVivo Holdings, Inc. John Lai, Chief Executive Officer of PetVivo Holdings, Inc.MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings,…

MI4, Montreal’s powerhouse of infectious disease research, celebrates five years of innovation and philanthropy

3 years ago

Vincent Chiara, real estate entrepreneur and founder and President of Groupe Mach donates $1.4 million to the MUCH Foundation for…

Windtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime

3 years ago

WARRINGTON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is a biotechnology…

Psychedelic Science Announces Sessions and Select Featured Speakers for Science and Research Tracks for 2023 Conference

3 years ago

Dr. Roland Griffiths Announced to Lead Discussions on the Science and Research of Psychedelics Featured Speakers Includes Dr. Matthew Johnson,…

Humacyte, JDRF Collaborating to Develop Insulin-Producing Biovascular Pancreas to Treat Type 1 Diabetes

3 years ago

NEW YORK, N.Y. and DURHAM, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a biotechnology company pioneering…

Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

3 years ago

PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that…